India · Delayed Price · Currency is INR Nectar Lifesciences Company Description
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally.
The company’s active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine.
It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins.
In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
| Country | India |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,686 |
| CEO | Amit Chadah |
Contact Details
Address: SCO 38-39 Chandigarh, 160009 India | |
| Phone | 91 17 2504 7915 |
| Website | neclife.com |
Stock Details
| Ticker Symbol | NECLIFE |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE023H01027 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Amit Chadah | Chief Executive Officer |
| Sanjiv Goyal | Chairman and MD |
| Sushil Kapoor | Chief Financial Officer |
| Sanjaymohan Singh Rawat | Company Secretary and Compliance Officer |